Literature DB >> 12188021

Modified AutoDock for accurate docking of protein kinase inhibitors.

Oleksandr V Buzko1, Anthony C Bishop, Kevan M Shokat.   

Abstract

Protein kinases are an important class of enzymes controlling virtually all cellular signaling pathways. Consequently, selective inhibitors of protein kinases have attracted significant interest as potential new drugs for many diseases. Computational methods, including molecular docking, have increasingly been used in the inhibitor design process [1]. We have considered several docking packages in order to strengthen our kinase inhibitor work with computational capabilities. In our experience, AutoDock offered a reasonable combination of accuracy and speed, as opposed to methods that specialize either in fast database searches or detailed and computationally intensive calculations. However, AutoDock did not perform well in cases where extensive hydrophobic contacts were involved, such as docking of SB203580 to its target protein kinase p38. Another shortcoming was a hydrogen bonding energy function, which underestimated the attraction component and, thus, did not allow for sufficiently accurate modeling of the key hydrogen bonds in the kinase-inhibitor complexes. We have modified the parameter set used to model hydrogen bonds, which increased the accuracy of AutoDock and appeared to be generally applicable to many kinase-inhibitor pairs without customization. Binding to largely hydrophobic sites, such as the active site of p38, was significantly improved by introducing a correction factor selectively affecting only carbon and hydrogen energy grids, thus, providing an effective, although approximate, treatment of solvation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188021     DOI: 10.1023/a:1016366013656

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  46 in total

1.  Continuum electrostatic analysis of preferred solvation sites around proteins in solution.

Authors:  S Dennis; C J Camacho; S Vajda
Journal:  Proteins       Date:  2000-02-01

2.  Scoring functions: a view from the bench.

Authors:  J R Tame
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

Review 3.  Solvation effects.

Authors:  W G Richards; P M King; C A Reynolds
Journal:  Protein Eng       Date:  1989-01

4.  1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

Authors:  J Dumas; H Hatoum-Mokdad; R Sibley; B Riedl; W J Scott; M K Monahan; T B Lowinger; C Brennan; R Natero; T Turner; J S Johnson; R Schoenleber; A Bhargava; S M Wilhelm; T J Housley; G E Ranges; A Shrikhande
Journal:  Bioorg Med Chem Lett       Date:  2000-09-18       Impact factor: 2.823

5.  Design of allele-specific inhibitors to probe protein kinase signaling.

Authors:  A C Bishop; K Shah; Y Liu; L Witucki; C Kung; K M Shokat
Journal:  Curr Biol       Date:  1998-02-26       Impact factor: 10.834

6.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

7.  Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors.

Authors:  J S Tokarski; A J Hopfinger
Journal:  J Chem Inf Comput Sci       Date:  1997 Jul-Aug

8.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

9.  Engineering Src family protein kinases with unnatural nucleotide specificity.

Authors:  Y Liu; K Shah; F Yang; L Witucki; K M Shokat
Journal:  Chem Biol       Date:  1998-02

Review 10.  Type I receptor tyrosine kinases as targets for therapy in breast cancer.

Authors:  J Baselga; J Mendelsohn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

View more
  10 in total

1.  Evaluation of different virtual screening programs for docking in a charged binding pocket.

Authors:  Wei Deng; Christophe L M J Verlinde
Journal:  J Chem Inf Model       Date:  2008-09-27       Impact factor: 4.956

Review 2.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

3.  Accelerating AutoDock4 with GPUs and Gradient-Based Local Search.

Authors:  Diogo Santos-Martins; Leonardo Solis-Vasquez; Andreas F Tillack; Michel F Sanner; Andreas Koch; Stefano Forli
Journal:  J Chem Theory Comput       Date:  2021-01-06       Impact factor: 6.006

4.  Predicting a small molecule-kinase interaction map: A machine learning approach.

Authors:  Fabian Buchwald; Lothar Richter; Stefan Kramer
Journal:  J Cheminform       Date:  2011-06-27       Impact factor: 5.514

5.  Three-dimensional mapping of differential amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic activation by lipid A, antagonism by Eritoran and species-dependent activities of Lipid IVA in the mammalian LPS sensor system.

Authors:  Thomas Scior; Jorge Lozano-Aponte; Vianihuini Figueroa-Vazquez; Julian A Yunes-Rojas; Ulrich Zähringer; Christian Alexander
Journal:  Comput Struct Biotechnol J       Date:  2013-08-08       Impact factor: 7.271

6.  A computational protocol to evaluate the effects of protein mutants in the kinase gatekeeper position on the binding of ATP substrate analogues.

Authors:  Valentina Romano; Tjaart A P de Beer; Torsten Schwede
Journal:  BMC Res Notes       Date:  2017-02-20

7.  Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders.

Authors:  S Shashidhar Bharadwaj; Boja Poojary; Sharath Kumar M Nandish; Jayanna Kengaiah; Mugaranja P Kirana; Madan Kumar Shankar; Anupam J Das; Ananda Kulal; Devaraja Sannaningaiah
Journal:  ACS Omega       Date:  2018-10-03

8.  Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? - A computational approach.

Authors:  Thomas Scior; Hassan H Abdallah; Siti Fatimah Zaharah Mustafa; José Antonio Guevara-García; Dieter Rehder
Journal:  Inorganica Chim Acta       Date:  2021-02-11       Impact factor: 2.545

9.  Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.

Authors:  Thomas W Sturgill; Michael N Hall
Journal:  ACS Chem Biol       Date:  2009-12-18       Impact factor: 5.100

10.  AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins.

Authors:  Diogo Santos-Martins; Stefano Forli; Maria João Ramos; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2014-07-18       Impact factor: 4.956

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.